Abstract
No standards for staging, systemic therapy or the timing of an operation are defined
for patients newly diagnosed with synchronous metastases and a primary in the colon.
An expert group of radiologists, medical, radiation and surgical oncologists therefore
came together to discuss staging and treatment sequence for these patients and came
up with a recommendation based on current evidence of potential therapeutic options.
The discussion was organized to debate recommendations centred on 5 topics and therefore
the position paper is built upon these titles and their subtitles.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Digestive and Liver DiseaseAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Surgical resection of colorectal carcinoma metastases to the liver.Cancer. 1996; 77: 1254-1262
- Randomized multicentre trial of gadoxetic acid-enhanced MRIversus conventional MRI or CT in the staging of colorectal cancer liver metastases.British Journal of Surgery. 2014; 101: 613-621
- The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation.Health Technology Assessment. 2011; 15: 192
- Treatment strategies for colorectal carcinoma with synchronous liver metastases: which way to go?.World Journal of Gastroenterology. 2015; 21: 7014-7021
- Experts reviews of the multidisciplinary consensus conference colon and rectal cancer 2012: science, opinions and experiences from the experts of surgery.European Journal of Surgical Oncology (EJSO). 2014; 40: 454-468
- The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection.Gut. 2005; 54: 289-296
- Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel.Annals of Oncology. 2009; 20: 985-992
- Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Annals of Oncology. 2014; 25 (iii1–9)
- Improved outcomes of colorectal cancer patients with liver metastases in the era of the multidisciplinary teams.International Journal of Colorectal Disease. 2016; 31: 403-411
- Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases.Annals of Surgery. 1999; 230: 309-321
- The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.Journal of the National Cancer Institute. 1993; 85: 365-376
- The role of liver resection for colorectal cancer metastases in an era of multimodality treatment: A systematic review.Surgery. 2012; 151: 860-870
- Primary mFOLFOX6 Plus Bevacizumab without resection of the primary tumor for patients presenting with surgically unresectable metastatic colon cancer and an intact asymptomatic colon cancer: definitive analysis of NSABP Trial C-10.Journal of Clinical Oncology. 2012; 30: 3223-3228
- Prognostic value of resection of primary tumor in patients with stage IV colorectal cancer: retrospective analysis of two randomized studies and a review of the literature.Annals of Surgical Oncology. 2011; 18: 3252-3260
- The CAIRO4 study: the role of surgery of the primary tumour with few or absent symptoms in patients with synchronous unresectable metastases of colorectal cancer – a randomized phase III study of the Dutch Colorectal Cancer Group (DCCG).BMC Cancer. 2014; 14: 741
- Resection of the primary tumour versus no resection prior to systemic therapy in patients with colon cancer and synchronous unresectable metastases (UICC stage IV): SYNCHRONOUS – a randomised controlled multicentre trial (ISRCTN30964555).BMC Cancer. 2012; 12: 142
- Self-expandable metallic stents in patients with stage IV obstructing colorectal cancer.World Journal of Surgery. 2012; 36: 2931-2936
- Place of colorectal stents in therapeutic management of malignant large bowel obstructions.Endoscopy. 2014; 46: 546-552
- Self-expandable metal stents for obstructing colonic and extracolonic cancer: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline.Gastrointestinal Endoscopy. 2014; 80 (747–761.e775)
- Gastrointestinal perforation associated with bevacizumab use in metastatic colorectal cancer: results from a large treatment observational cohort study.European Journal of Cancer. 2012; 48: 1126-1132
- Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial.Lancet. 2008; 371: 1007-1016
- Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial.Lancet Oncology. 2013; 14: 1208-1215
- Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trial.Annals of Oncology. 2015; 26: 702-708
- Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial.Lancet Oncology. 2010; 11: 38-47
- Randomized controlled trial of cetuximab plus chemotherapy for patients with KRAS wild-type unresectable colorectal liver-limited metastases.Journal of Clinical Oncology. 2013; 31: 1931-1938
- ESMO consensus guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making.Annals of Oncology. 2012; 23: 2479-2516
- Is complete liver resection without resection of synchronous lung metastases justified?.Annals of Surgical Oncology. 2015; 22: 1585-1592
- Prolonged survival of initially unresectable hepatic colorectal cancer patients treated with hepatic arterial infusion of oxaliplatin followed by radical surgery of metastases.Annals of Surgery. 2010; 251: 686-691
- Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial.Lancet Oncology. 2012; 13: 1225-1233
- Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial.Lancet Oncology. 2014; 15: 862-873
- Propensity score-matched outcomes analysis of the liver-first approach for synchronous colorectal liver metastases.British Journal of Surgery. 2016; 103: 600-606
- Neoadjuvant FOLFOX 4 versus FOLFOX 4 with Cetuximab versus immediate surgery for high-risk stage II and III colon cancers: a multicentre randomised controlled phase II trial – the PRODIGE 22 – ECKINOXE trial.BMC Cancer. 2015; 15: 511
- Gadoxetic acid-enhanced 3.0 T MR imaging versus multidetector-row CT in the detection of colorectal metastases in fatty liver using intraoperative ultrasound and histopathology as a standard of reference.European Journal of Surgical Oncology. 2012; 38: 670-676
- Predictors of a true complete response among disappearing liver metastases from colorectal cancer after chemotherapy.Cancer. 2010; 116: 1502-1509
- Adjuvant chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative study between hepatic arterial infusion of oxaliplatin and modern systemic chemotherapy.Annals of Surgery. 2013; 257: 114-120
- The effect of a regional hepatopancreaticobiliary surgical program on clinical volume, quality of cancer care, and outcomes in the veterans affairs system.JAMA Surgery. 2014; 149: 1153-1161
- Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.Annals of Surgery. 2004; 240: 205-213
- Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004).Annals of Oncology. 2012; 23: 2619-2626
Article info
Publication history
Published online: June 30, 2016
Accepted:
June 9,
2016
Received:
January 20,
2016
Identification
Copyright
© 2016 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
